Skip to content

COCOCINEL: value indication

Line	Code	2024	2025	Change	%
Total assets	20/58	€4,705,202	€4,656,942	-€48,260	-1.0%
Fixed assets	21/28	€2,728,473	€2,727,366	-€1,106	0.0%
Tangible fixed assets	22/27	€1,410	€304	-€1,106	-78.5%
Plant, machinery and equipment	23	€804	€0	-€804	-100%
Furniture and vehicles	24	€606	€304	-€302	-49.9%
Financial fixed assets	28	€2,727,063	€2,727,063	=	0.0%
Affiliated companies	280/1	-	€2,725,063	+€2.7m
Participating interests	280	-	€2,725,063	+€2.7m
Companies linked by participating interests	282/3	-	€2,000	+€2,000
Participating interests	282	-	€2,000	+€2,000
Current assets	29/58	€1,976,729	€1,929,575	-€47,154	-2.4%
Stocks and contracts in progress	3	-	€0	=
Amounts receivable within one year	40/41	€1,948,446	€1,896,026	-€52,419	-2.7%
Trade receivables	40	€116,399	€114,740	-€1,659	-1.4%
Other amounts receivable	41	€1,832,046	€1,781,286	-€50,760	-2.8%
Cash at bank and in hand	54/58	€18,164	€22,777	+€4,613	+25.4%
Deferred charges and accrued income	490/1	€10,120	€10,772	+€652	+6.4%
Total equity and liabilities	10/49	€4,705,202	€4,656,942	-€48,260	-1.0%
Equity	10/15	€1,261,132	€1,263,075	+€1,944	+0.2%
Contributions	10/11	€125,000	€125,000	=	0.0%
Reserves	13	€1,136,132	€1,138,075	+€1,944	+0.2%
Non-distributable reserves	130/1	€12,500	€12,500	=	0.0%
Reserves not available under the articles	1311	€12,500	€12,500	=	0.0%
Distributable reserves	133	€1,123,632	€1,125,575	+€1,944	+0.2%
Amounts payable	17/49	€3,444,070	€3,393,867	-€50,204	-1.5%
Amounts payable after more than one year	17	€175,000	€175,000	=	0.0%
Financial debts	170/4	€175,000	€175,000	=	0.0%
Subordinated loans	170	-	€175,000	+€175,000
Amounts payable within one year	42/48	€3,267,118	€3,217,754	-€49,365	-1.5%
Current portion of amounts payable after more than one year	42	€158,889	€24,893	-€133,995	-84.3%
Financial debts	43	€140,000	€105,000	-€35,000	-25.0%
Credit institutions	430/8	€140,000	€105,000	-€35,000	-25.0%
Trade debts	44	€156,572	€561,583	+€405,011	+259%
Suppliers	440/4	€156,572	€561,583	+€405,011	+259%
Taxes, remuneration and social security	45	€103,886	€88,296	-€15,590	-15.0%
Taxes	450/3	€56,778	€3,853	-€52,925	-93.2%
Remuneration and social security	454/9	€47,108	€84,443	+€37,336	+79.3%
Other amounts payable	47/48	€2,707,771	€2,437,981	-€269,791	-10.0%
Accrued charges and deferred income	492/3	€1,952	€1,113	-€839	-43.0%
Operating income	70/76A	-	€918,982	+€918,982
Turnover	70	-	€893,301	+€893,301
Other operating income	74	-	€25,682	+€25,682
Operating charges	60/66A	-	€1,074,000	+€1.1m
Services and other goods	61	-	€794,554	+€794,554
Remuneration, social security and pensions	62	€268,474	€265,508	-€2,966	-1.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets	630	€1,932	€1,106	-€825	-42.7%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)	631/4	€14,341	€0	-€14,341	-100%
Other operating charges	640/8	€1,549	€12,832	+€11,283	+729%
Gross operating margin	9900	€294,777	-	-€294,777
Operating profit (loss)	9901	€8,482	-€155,018	-€163,500
Financial income	75/76B	€181,674	€180,162	-€1,513	-0.8%
Recurring financial income	75	€181,674	€180,162	-€1,513	-0.8%
Income from financial fixed assets	750	-	€179,992	+€179,992
Other financial income	752/9	-	€169	+€169
Financial charges	65/66B	€23,675	€22,672	-€1,004	-4.2%
Recurring financial charges	65	€23,675	€22,672	-€1,004	-4.2%
Debt charges	650	-	€20,571	+€20,571
Other financial charges	652/9	-	€2,101	+€2,101
Profit (loss) for the period before taxes	9903	€166,481	€2,472	-€164,009	-98.5%
Income taxes	67/77	€523	€528	+€5	+0.9%
Taxes	670/3	-	€528	+€528
Profit (loss) for the period	9904	€165,958	€1,944	-€164,014	-98.8%
Profit (loss) for the period to be appropriated	9905	€165,958	€1,944	-€164,014	-98.8%

COCOCINEL: value indication

COCOCINEL: value indication

Position among the sector peers

What moved between 2024 and 2025

Largest movements

Change in the result, 2024 to 2025

Derived cash bridge

Value

Indicative value of the equity

Adjusted equity

Capitalised earnings

Your EBITDA multiple

Limits of the indication

Next steps